Brukinsa had a lower risk of disease progression or death versus Imbruvica, as well as a more favorable safety profile, in R/R CLL and SLL.

Heart failure is a condition that occurs when the heart can’t pump as well as it should. This may happen when the heart muscle becomes weak or stiff. As a result, it doesn’t deliver enough blood to ...